Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
20.30
-0.70 (-3.33%)
May 28, 2026, 10:20 AM HKT
HKG:1877 Market Cap
HKG:1877 has a market cap or net worth of 35.85 billion as of May 27, 2026. Its market cap has increased by 26.98% in one year.
Market Cap
35.85B
Enterprise Value
37.68B
Revenue
3.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
20.30
Market Cap Chart
Since December 24, 2018, HKG:1877's market cap has increased from 18.06B to 35.85B, an increase of 98.55%. That is a compound annual growth rate of 9.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 35.83B | 3.38% |
| Dec 31, 2025 | 34.66B | 39.72% |
| Dec 31, 2024 | 24.81B | -37.28% |
| Dec 29, 2023 | 39.55B | -38.85% |
| Dec 30, 2022 | 64.67B | -7.04% |
| Dec 31, 2021 | 69.57B | -9.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RemeGen | 65.18B |
| 3SBio | 48.09B |
| Biocytogen Pharmaceuticals (Beijing) | 46.03B |
| Shanghai Henlius Biotech | 38.45B |
| Genscript Biotech | 28.38B |
| InnoCare Pharma | 24.94B |
| Duality Biotherapeutics | 20.12B |
| Metis TechBio | 19.45B |